Definitive Healthcare Corp.(DH)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,597 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
DH Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Definitive Healthcare Corp. (DH), a Technology sector company. 13F Pro's AI-powered ranking engine scores DH at 27.0/100 on a 32-signal composite quality model, placing it at rank #2,597 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (8.7) and profitability (9.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Definitive Healthcare Corp. reports quarterly revenue of $55.2M, net income of $-5.4M, free cash flow of $8.5M. Top institutional holders of DH by reported 13-F value include ADVENT INTERNATIONAL, L.P., GOLDMAN SACHS GROUP, D. E. Shaw, based on the most recent SEC filings. DH trades on the Nasdaq exchange and files with the SEC under CIK 1861795. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Definitive Healthcare Corp. directly from SEC EDGAR. Definitive Healthcare Corp.'s 13F Pro composite quality score has ranged between 24 and 48 since 2022, currently 27.0 — a declining long-term trajectory across 64 quarterly and live scoring snapshots.
Revenue
Q2 2026
$55.2M
Net Income
Q2 2026
$-5.4M
Free Cash Flow
Q2 2026
$8.5M
ROIC
Q2 2026
-7.6%
D/E Ratio
Q2 2026
0.90
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-4.2% YoYNet Income
+66.4% YoYOperating Income
+68.4% YoYEPS (Diluted)
+63.3% YoYTotal Assets
-32.5% YoYTotal Debt
-32.3% YoYOp. Cash Flow
-7.6% YoYFree Cash Flow
-19.2% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $241.5M -4.2% | $252.2M +0.3% | $251.4M +12.9% | $222.7M +34.0% | $166.2M +40.4% | $118.3M |
| Net Income | $-138.9M +66.4% | $-413.1M -104.1% | $-202.4M -2702.4% | $-7.2M +59.5% | $-17.8M | $0.00 |
| Operating Income | $-224.3M +68.4% | $-710.8M -115.5% | $-329.8M -648.8% | $-44.0M -61.2% | $-27.3M -72.0% | $-15.9M |
| EPS (Diluted) | $-1.30 +63.3% | $-3.54 -97.8% | $-1.79 -2457.1% | $-0.07 +63.2% | $-0.19 | — |
| Total Assets | $735.5M -32.5% | $1.09B -40.3% | $1.83B -14.0% | $2.12B +0.2% | $2.12B +21.2% | $1.75B |
| Total Debt | $183.8M -32.3% | $271.6M -4.8% | $285.3M +0.6% | $283.6M -1.2% | $287.0M -38.5% | $466.6M |
| Operating Cash Flow | $53.8M -7.6% | $58.2M +41.3% | $41.2M +15.8% | $35.6M +41.1% | $25.2M +8.6% | $23.2M |
| Free Cash Flow | $37.1M -19.2% | $45.9M +20.0% | $38.2M +40.2% | $27.3M +47.5% | $18.5M -15.3% | $21.8M |
Get alerted when DH's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Definitive Healthcare Corp. including:
Top Institutional Holders of DH
ADVENT INTERNATIONAL, L.P.
$51.9M62,493,676 shGOLDMAN SACHS GROUP INC
$5.0M5,959,143 shD. E. Shaw & Co., Inc.
$1.6M1,973,193 shVANGUARD CAPITAL MANAGEMENT LLC
$1.5M1,829,463 shKENNEDY CAPITAL MANAGEMENT LLC
$1.4M1,737,044 shDIMENSIONAL FUND ADVISORS LP
$1.2M1,453,209 shBlackRock, Inc.
$1.2M1,408,621 shAQR CAPITAL MANAGEMENT LLC
$747.1K899,132 shInspire Investing, LLC
$743.6K894,949 shGEODE CAPITAL MANAGEMENT, LLC
$457.9K550,753 sh
| Fund | Value | Shares |
|---|---|---|
| ADVENT INTERNATIONAL, L.P. | $51.9M | 62,493,676 |
| GOLDMAN SACHS GROUP INC | $5.0M | 5,959,143 |
| D. E. Shaw & Co., Inc. | $1.6M | 1,973,193 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.5M | 1,829,463 |
| KENNEDY CAPITAL MANAGEMENT LLC | $1.4M | 1,737,044 |
| DIMENSIONAL FUND ADVISORS LP | $1.2M | 1,453,209 |
| BlackRock, Inc. | $1.2M | 1,408,621 |
| AQR CAPITAL MANAGEMENT LLC | $747.1K | 899,132 |
| Inspire Investing, LLC | $743.6K | 894,949 |
| GEODE CAPITAL MANAGEMENT, LLC | $457.9K | 550,753 |
Companies Similar to DH
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
SYPRIS SOLUTIONS INC
Health Catalyst, Inc.
KALTURA INC
SOUNDTHINKING, INC.
STEM, INC.
CS Disco, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Technology Companies
View all Technology →Put DH on your watchlist
Track score changes the day Definitive Healthcare Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is DH a good stock to buy?
13F Pro's AI-powered analysis of Definitive Healthcare Corp. (DH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DH are available on the DH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. DH is classified as a small company.
Which hedge funds own DH?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Definitive Healthcare Corp.'s investment landscape.